Syndicate content Barron's Features
Barron's Features
Updated: 1 year 19 weeks ago

The Brief, January 2

Thu, 01/03/2019 - 05:11
All three major U.S. stock indexes ended higher on an indecisive day for the market.

Winton Capital's Idiosyncratic Founder on Artificial Intelligence and Statistical Fallacies

Wed, 01/02/2019 - 22:00
David Harding is unusual in a London hedge fund scene dominated by Mayfair-based M.B.As. Educated in physics, he has used statistics and computer technology to build one of the largest funds in the U.K.

Market for Streaming Starts to Look a Little Like Cable

Sat, 12/29/2018 - 08:47
Disney wants to be a niche service, but on a massive scale.

What Will 2019 Bring for Investors? Take Our Annual Forecasting Quiz

Sat, 12/29/2018 - 06:28
What will markets and companies do in the year ahead?

High Fees Are Hurting Returns for a Surprising Number of Index Funds

Sat, 12/29/2018 - 03:44
One of the appeals of index funds is supposed to be their low cost. But investors are paying annual fees of 1% and more for some funds

Dell's Public Debut Produces Fresh Winners and Losers

Fri, 12/28/2018 - 23:40
Those who took cash instead of Dell stock in the company’s buyout of holders of its VMware tracker came out ahead in Friday’s deal.

Our Most-Read and Most-Shared Stories of 2018

Fri, 12/28/2018 - 03:22
Readers loved roundtables, retirement stories, stock-picking screens, and guides to finding yield

Rising Interest Rates Complicate the Corporate Borrowing Spree

Mon, 12/24/2018 - 23:16
The days when Fed-engineered low rates made everyone a winner are over. As as companies refinance their debt—some more urgently than others—investors have to make more complex calculations.

Small-Caps, Big Problems: How to Pick and Choose

Mon, 12/24/2018 - 23:12
Small-caps peaked in August, then lost ground on a variety of fears. For 2019, investors will need to avoid the indexes and do some stock picking. There are small-cap winners.

The Right Rx for Health-Care Investors

Mon, 12/24/2018 - 22:26
Forget about Johnson & Johnson’s baby powder woes. Instead, consider the shares of CVS Health, Laboratory Corp. of America Holdings, and Teledoc Health

Where To Find Treasures in Europe's Bear Market

Mon, 12/24/2018 - 22:24
After falling about 25%, some of the region’s stocks hold a lot of long-term value. Among the best: BP and BASF. We offer three additional picks.

The Unicorns Are Coming to Market

Sat, 12/22/2018 - 09:06
Uber, Lyft, and other richly valued start-ups are getting ready to go public, but the ride could be rocky with the Nasdaq selling off.

How 2018's Major IPOs Performed

Sat, 12/22/2018 - 07:09
The number of IPOs has gone up in 2018, but returns have been disappointing.

Are Bank Stocks Predicting the Next Recession?

Thu, 12/20/2018 - 16:00
New research finds that the group is pricing in a milder slowdown, even as many individual stocks trade at bear-market levels.

Industrial Firms Want in on the Subscriptions Bonanza, Too

Sat, 12/15/2018 - 19:30
Subscriptions are already remaking the consumer and technology worlds. Now industrial companies are thinking about their own Netflix-like models.

Top 10 Stock Picks for 2019

Sat, 12/15/2018 - 07:30
Valuations still look attractive despite the recent market turmoil. Why we like

6 Ways to Avoid a Big Tax Bill Surprise

Tue, 12/11/2018 - 01:45
The new tax rules lower rates and, in some cases, allow larger deductions.

Lessons From the Bernie Madoff Fraud, 10 Years Later

Mon, 12/10/2018 - 21:56
Sophisticated Ponzi schemes persist even after regulatory changes. Here are some of the warning flags that investors should keep in mind.

Applied Materials Stock Is a Cheap Bet on Big Data

Sat, 12/08/2018 - 17:00
Worries about U.S.-Chinese trade relations and the state of the semiconductor business have taken the shares down sharply since March. Just maintaining its current multiple could push the stock up 30% next year.

Michael Dell's Latest Deal Could Yield a Cheap New Stock

Sat, 12/08/2018 - 16:30
The encore to Dell Technologies’ contentious buyout of Dell’s VMware tracking stock could be worth waiting for.